Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Case Reports in Medicine|May 27, 2017
A Case of Urachal Carcinoma of the Abdominal Wall in a Kidney Transplant RecipientTakuya Yamazaki, Yasushi Nagaba, Yoshitaka Shimada, et al.BMC Urology|May 13, 2022
Impact of salvage cytotoxic chemotherapy on prognosis in patients with recurrence after radical cystectomy: a multi-institutional retrospective studyDai Koguchi, Kazumasa Matsumoto, Masaomi Ikeda, et al.Cancers|December 30, 2025
A Comparative Analysis of the Functional Outcomes Between Retzius-Sparing and Conventional Robot-Assisted Radical Prostatectomy Using the Expanded Prostate Cancer Index CompositeSoichiro Shimura, Dai Koguchi, Ken-Ichi Tabata, et al.Japanese Journal of Clinical Oncology|February 2, 2024
Real-world data on the comprehensive genetic profiling test for Japanese patients with metastatic castration-resistant prostate cancerDai Koguchi, Hideyasu Tsumura, Ken-Ichi Tabata, et al.The Prostate|March 3, 2026
Defining Favorable Prognosis in Bone Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Receptor Signaling InhibitorsDai Koguchi, Hideyasu Tsumura, Ken-Ichi Tabata, et al.Asia-Pacific Journal of Clinical Oncology|August 1, 2022
Noninferior oncological outcomes in adults aged 80 years or older compared with younger patients who underwent radical nephroureterectomy for upper tract urothelial carcinomaYasufumi Yamada, Masaomi Ikeda, Takahiro Hirayama, et al.Asia-Pacific Journal of Clinical Oncology|April 11, 2022
A multi-institutional retrospective study of open versus laparoscopic nephroureterectomy focused on the intravesical recurrenceSoichiro Shimura, Kazumasa Matsumoto, Masaomi Ikeda, et al.Chemotherapy|April 7, 2022
Patients with Non-Muscle-Invasive Bladder Cancer Previously Treated with Nephroureterectomy Have a High Risk of Recurrence after Bacillus Calmette-Guérin Intravesical Instillation TherapyRyota Maeyama, Masaomi Ikeda, Soichiro Shimura, et al.Urologia Internationalis|January 16, 2023
Efficacy of Intravesical Instillation Therapy with Low-Dose Tokyo-172 Bacillus Calmette-Guérin to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer and Treat Carcinoma in situ: A Multi-Institutional Retrospective StudyTakashi Tachibana, Masaomi Ikeda, Soichiro Shimura, et al.Cancers|April 26, 2025
Association Between CKAP4 Expression and Poor Prognosis in Patients with Bladder Cancer Treated with Radical CystectomyHiroki Katsumata, Dai Koguchi, Shuhei Hirano, et al.Pageof 5